1). Tebruegge M., Curtis N. Enterovirus infections in neonates. Semin in Fetal Neonatal Med. 2009. 14:222–7.
Article
2). Romero JR. Pediatric group B coxsackievirus infections. Curr Top Microbiol Immunol. 2008. 323:223–39.
Article
3). Modlin JF. Perinatal echovirus and group B coxsackievirus infections. Clin Perinatol. 1988. 15:233–46.
4). Bryant PA., Tingay D., Darqaville PA., Starr M., Curtis N. Neonatal coxsakie B virus infection-a treatable disease? Eur J Pediatr. 2004. 163:223–8.
5). Isacsohn M., Eidelman AI., Kaplan M., Goren A., Rudensky B., Handsher R, et al. Neonatal coxsackievirus group B infections: experience of a single department of neonatology. Isr J Med Sci. 1994. 30:371–4.
6). Jenista JA., Powell KR., Menegus MA. Epidemiology of neonatal enterovirus infection. J Pediatr. 1984. 104:685–90.
Article
7). Huebner RJ., Cole RM., Beeman EA., Bell JA., Peers JH. Herpangina; etiological studies of a specific infectious disease. J Am Med Assoc. 1951. 145:628–33.
8). Bendig JW., Franklin OM., Hebden AK., Backhouse PJ., Clewley JP., Goldman AP, et al. Coxsackievirus B3 sequences in the blood of a neonate with congenital myocarditis, plus serological evidence of maternal infection. J Med Virol. 2003. 70:606–9.
Article
9). Kaplan MH., Klein SW., McPhee J., Harper RG. Group B coxsackie virus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis. 1983. 5:1019–32.
10). Cheng LL., Ng PC., Chan PK., Wong HL., Cheng FW., Tang JW. Probable intrafamilial transmission of coxsackievirus b3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding. Pediatrics. 2006. 118:e929–33.
Article
11). Khetsuriani N., Lamonte A., Oberste MS., Pallansch M. Neonatal enterovirus infections reported to the national enterovirus surveillance system in the United States, 1983-2003. Pediatr Infect Dis J. 2006. 25:889–93.
Article
12). Lee HJ., Choi CW., Kim EK., Kim HS., Kim BI., Choi JH. A Case of Perinatal Echovirus 30 Infection in a Premature Infant. Korean J Perinatol. 2010. 21:81–5.
13). Lin TY., Kao HT., Hsieh SH., Huang YC., Chiu CH., Chou YH, et al. Neonatal enterovirus infections: emphasis on risk factors of severe and fatal infections. Pediatr Infect Dis J. 2003. 22:889–94.
Article
14). Abzug MJ., Levin MJ., Rotbart HA. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J. 1993. 12:820–4.
Article
15). Lu JC., Koay KW., Ramers CB., Milazzo AS. Neonate with coxsackie B1 infection, cardiomyopathy and arrhythmias. J Natl Med Assoc. 2005. 97:1028–30.
16). Wilfert CM., Thompson Jr RJ., Sunder TR., O'Quinn A., Zeller J., Blacharsh J. Longitudinal assessment of children with enteroviral meningitis during the first three months of life. Pediatrics. 1981. 67:811–5.
Article
17). Rotbart HA., O'Connell JF., McKinlay MA. Treatment of human enterovirus infection. Antiviral Res. 1998. 38:1–14.
18). Bauer S., Gottesman G., Sirota L., Litmanovitz I., Ashkenazi S., Levi I. Severe Coxsakie virus B infection in preterm newborns treated with pleoconaril. Eur J Pediatr. 2002. 161:491–3.